Tenofovir (Viread): Basics

An Overview of Viread (Tenofovir) (September 21, 2012)
From AIDSinfo
Viread (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Tenofovir (Viread) (January 21, 2012)
To read PDF, click here.
From AIDS InfoNet
Patient Information About Viread (Tenofovir) (PDF) (January 2012)
From Gilead Sciences, Inc.
Viread (Tenofovir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Tenofovir (Viread) (August 15, 2006)
From AIDS Treatment Data Network
Viread (Tenofovir) (November 2005)
To read PDF, click here.
From The Center for AIDS
Drug Interactions: Tenofovir (August 2004)
From Project Inform
Gilead's Viread International Access Program (May 2003)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Tenofovir: New Kind of Anti-HIV Drug Gets Approved (March 2002)
In Project Inform Perspective, from Project Inform
Tenofovir DF 300 mg Consistently Demonstrates Anti-HIV Activity Regardless of Baseline Demographic Characteristics in Antiretroviral Experienced HIV-1-Infected Patients (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from TheBodyPRO.com
FDA Briefing Documents on Tenofovir (October 3, 2001)
From U.S. Food and Drug Administration
Position Paper on NDA 21-356 for Gilead Sciences' Viread Brand Tenofovir Disoproxil Fumarate (October 3, 2001)
In TAGline, from Treatment Action Group
New Drugs in Development: Very Viread (Fall 2001)
A look at the drug's indications, resistance profile and some clinical trial results.
To read PDF, click here.
In CRIA Update, from AIDS Community Research Initiative of America

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's New! TheBody.com App
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.